KLF15 and diabetes mellitus: The upregulation of KLF15 in hyperglycemia (Box 1) leads to the activation of genes involved in protein catabolism and muscle atrophy, highlighting KLF15 as a potential therapeutic target for managing skeletal muscle decline in diabetes mellitus (Hirata et al., 2019).